Literature DB >> 16502166

Quality assurance guidelines for superior vena cava stenting in malignant disease.

Raman Uberoi1.   

Abstract

Superior vena cava stenting for the treatment of malignant superior vena cava obstruction is now well established. It offers simple, rapid, and safe palliation of a distressing and potentially fatal complication of mediastinal malignant disease and compares very favorably with standard therapies such as chemotherapy and radiotherapy. The following are quality assurance guidelines for superior vena cava stenting.

Entities:  

Mesh：

Year:  2006        PMID： 16502166     DOI： 10.1007/s00270-005-0284-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  20 in total

1.  Use of transoesophageal echocardiography in endovascular stenting for superior vena cava syndrome.

Authors:  Felipe Nasser; Rafael Noronha Cavalcante; Francisco Leonardo Galastri; Breno Boueri Affonso
Journal:  BMJ Case Rep       Date:  2013-08-30

2.  Pulseless Electrical Activity Arrest after SVC Dilation.

Authors:  Brian Funaki; Taral Doshi
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

3.  [Diagnostics and endovascular treatment of venous diseases].

Authors:  L Kamper; A Altenburg; M Das; P Haage
Journal:  Radiologe       Date:  2017-09       Impact factor: 0.635

4.  Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.

Authors:  Susanne Anton; T Oechtering; E Stahlberg; F Jacob; M Kleemann; J Barkhausen; J P Goltz
Journal:  Support Care Cancer       Date:  2017-12-22       Impact factor: 3.603

Review 5.  Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments.

Authors:  Keith B Quencer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

6.  Palliative treatment of superior vena cava syndrome with nitinol stents.

Authors:  Poul Erik Andersen; Stevo Duvnjak
Journal:  Int J Angiol       Date:  2014-12

7.  Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?

Authors:  Younghoon Cho; Dong Il Gwon; Gi-Young Ko; Heung Kyu Ko; Jin Hyoung Kim; Ji Hoon Shin; Hyun-Ki Yoon; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

Review 8.  Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond.

Authors:  Tamir Friedman; Keith B Quencer; Sirish A Kishore; Ronald S Winokur; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

9.  Endovascular Stenting in 2 Patients with Benign Superior Vena Cava Syndrome.

Authors:  Jared B Hooker; Beau M Hawkins; Mazen S Abu-Fadel
Journal:  Tex Heart Inst J       Date:  2018-08-01

10.  Combined rheolytic thrombectomy and stent placement in SVC and brachiocephalic vein thrombosis due to metastatic lymphadenopathy.

Authors:  Nikolaos Ptohis; Symeon Lechareas; Loukia Poulou; Stamatina Pagoni; Georgios Charalampopoulos; Dimitrios Filippiadis
Journal:  Radiol Case Rep       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.